Article and Video CATEGORIES
Dr. David Spigel, Sarah Cannon Cancer Center, describes current research in immunotherapy as treatment for squamous lung cancer.
[powerpress]
Squamous Lung Cancer, Part 4: Immunotherapy Audio Podcast
What you’ll hear in Part 4:
- Immunotherapy treatment for squamous lung cancer
Glossary of some terms you’ll hear in Part 4:
Find more cancer definitions at the National Cancer Institute’s Dictionary of Cancer Terms
- Adenocarcinoma – Cancer that begins in glandular (secretory) cells. Glandular cells are found in tissue that lines certain internal organs and makes and releases substances in the body, such as mucus, digestive juices, or other fluids. Most cancers of the breast, pancreas, lung, prostate, and colon are adenocarcinomas.
- Antibody therapy – Treatment with an antibody, a substance that can directly kill specific tumor cells or stimulate the immune system to kill tumor cells.
- Immunotherapy – A type of biological therapy that uses substances to stimulate or suppress the immune system to help the body fight cancer, infection, and other diseases.
- Receptor – A molecule inside or on the surface of a cell that binds to a specific substance and causes a specific effect in the cell.
- Squamous lung cancer – One of the three sub-types of lung cancer.
Please feel free to offer comments and raise questions in our
discussion forums.
Forum Discussions
Hi elysianfields and welcome to Grace. I'm sorry to hear about your father's progression.
Unfortunately, lepto remains a difficult area to treat. Recently FDA approved the combo Lazertinib and Amivantamab...
Hello Janine, thank you for your reply.
Do you happen to know whether it's common practice or if it's worth taking lazertinib without amivantamab? From all the articles I've come across...
Hi elysianfields,
That's not a question we can answer. It depends on the individual's health. I've linked the study comparing intravenous vs. IV infusions of the doublet lazertinib and amivantamab...
Recent Comments
That's…